Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with chronic glaucoma (any type) in at least one eye, with confirmed damage to the structure of the eye shown by imaging tests.
- Your glaucoma has also caused measurable loss in your field of vision, detected through a standard visual field test.
- You have had at least 4 reliable visual field tests done before joining the study.
- You are between 50 and 75 years old.
- If both of your eyes are affected, the eye with the worse vision loss would be the one studied.
Who may not be able to join:
- You have taken any vitamin or nutritional supplement in the month before screening.
- You have a neurological condition, a retinal disease, significant cataracts, or take a medication called Pregabalin (Lyrica), as these can affect visual field test results.
- You have a known allergy or sensitivity to aspirin, due to a possible related reaction with one of the study treatments (confirm with trial site).
- You have had eye surgery or laser treatment on your eye in the 3 months before joining, or have any planned during the study.
- Your visual field loss is either very mild or very severe, falling outside a specific range on a standard measurement scale (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +34 93 4340553
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from baseline in visual function assessed by Mean Deviation (MD) at 12 months; Change from baseline in visual function assessed by Visual Field Index (VFI) at 12 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.